The Keosys Blog

Pierre Terve | Chief Scientific Officer Jul 27, 2020

Imaging and the Treatment of Prostate Cancer: A Productive Relationship

First described in 1853, prostate cancer was originally thought to be rare...

Pierre Terve | Chief Scientific Officer Jun 18, 2020

Interventional Radiology: From “Angioplasty” to Leadership in 21st-Century Innovation

The seeds of the discipline that would become interventional radiology, the use..

Pierre Terve | Chief Scientific Officer Sep 24, 2019

Cross-calibrating PET Scanners in Clinical Trials: Why and How

Numerous elements of PET imaging are subject to variability, such as scan..

Pierre Terve | Chief Scientific Officer Jun 5, 2019

The Challenges of Imaging Biomarker Development

Imaging biomarkers are often pivotal components of a clinical trial, from..

Pierre Terve | Chief Scientific Officer Mar 19, 2019

RANO Criteria for Clinical Trials

An earlier post provided a broad overview of the various imaging criteria that..

Pierre Terve | Chief Scientific Officer Jan 22, 2019

Dosimetry and Its Use in Clinical Trials

Nuclear imaging-based biomarkers and targeted radiotherapy are integral..

Pierre Terve | Chief Scientific Officer Nov 30, 2018

What is Nuclear Imaging?

As noted in a previous post, positron emission tomography (PET)—a nuclear..

Pierre Terve | Chief Scientific Officer Nov 6, 2018

Choosing the Appropriate Imaging Modality and Imaging Criteria for Your Target Condition

The application of advanced imaging methods streamlines the clinical trial..

Pierre Terve | Chief Scientific Officer Oct 10, 2018

The Evolution of Keosys

It’s been 10 years since we made our foray into the clinical trial arena, and..

Pierre Terve | Chief Scientific Officer Sep 28, 2018

A Quick Guide to Medical Imaging in Clinical Trials

Medical imaging is a key asset in the drug development process as it can..

All posts

Recent